Article
Mast cell leukemia with novel BRAF variant and concomitant atypical KIT variant.
Cancer genetics - 1 Aug 2022
Chen Tiane, Malysz Jozef, Washburn Erik, Songdej Natthapol, Zhang Yong, Bayerl Michael
Abstract excerpt
Mast cell leukemia (MCL) is a leukemic variant of systemic mastocytosis defined by mast cells ≥ 20% of marrow nucleated cells. Its incidence is < 1% of all systemic mastocytosis cases [1]. Clinical characteristics and treatment of the disease are not well established and overall prognosis is very poor. We report a case of de novo mast cell leukemia with novel BRAF variant, concomitant KIT exon 9 missense mutation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
